(a) Predicted linear structure of APOL1, using JPred, with major sites of amino acid variation highlighted in red (a deletion is represented as a dash). Haplotypes are organized by frequency in the …
(a) A time-course of APOL1 expression in FT293 cells treated with 50 ng/mL doxycycline reveals that RRV cytotoxicity occurs 24 hr post-induction (n = 3). Data are represented as mean ± s.d. (b) …
(a) Planar lipid bilayer setup. The starting buffer composition for (b–d) are shown. During each experiment the composition of the cis side is altered by the experimenter, whereas the trans side is …
(a) Fluorescence traces of representative GCaMP6f-positive cells demonstrating that G1 and G2 cause a Ca2+ influx prior to cell swelling. GCaMP6f-transfected FT293 cells were incubated with DRAQ7 …
FT283 cells GCaMP6f microscopy, 30 hours after induction one way ANOVA.
(a) Schematic of the RUSH system. Streptavidin was expressed with a signal peptide and KDEL allowing for localization and retention in the ER lumen along with streptavidin-binding protein (SBP) …
(a) Western blot of whole cell lysates displaying protein expression of RUSH-APOL1 in HEK293 cells 24 hr after transfection. Cells were not treated with biotin. (b) Fluorescent traces of all …
(a) Validation for the simultaneous use of Ca2+ sensors GCaMP6f and ER-LAR-GECO from a representative cell. Co-transfected cells were treated with 10 µM thapsigargin to prevent Ca2+ reuptake in the …
(a) Confocal images of transfected and permeabilized CHO cells depict RUSH-APOL1 (red) localized to the ER (stained via calnexin, green) without biotin followed by partial PM localization after 90 …
Additional confocal images of immunostained CHO cells from Figure 5a. All three APOL1 variants are found in the ER prior to biotin treatment, and then traffic to the peri-nuclear region or PM within …
(a) Schematic of the planar lipid bilayer setup showing the sequence of cis buffer perfusions. (b) The APOL1 channel is readily permeable to Na+, but not choline+. In symmetrical KCl solutions Erev …
RRV cytotoxicity is exacerbated with increased extracellular Ca2+. (a) Replacement of extracellular NaCl with KCl for 12 hr significantly reduces cell viability in RUSH-G0 transfected HEK293 cells …
Release of RUSH-G0 from the ER does not elicit a sustained increase in cytoplasmic Ca2+ or membrane depolarization. (a) Fluorescent trace of a representative CHO cell transfected with the plasma …
The G2-mediated Ca2+-influx occurs alongside a Na+ influx (as measured via membrane voltage) (n = 21). Cytoplasmic Ca2+ continues to increase for several hours while the membrane potential either …
CHO cells were co-transfected with RUSH-G2, GCaMP6f, and FliCR for 24 hr prior to imaging. On the day of the experiment cells were treated with 80 µM biotin and imaged every 5 min from 0.5 to 12 hr …
(a) Acidification and neutralization of RUSH-APOL1 transfected HEK293 cells causes G0 to become cytotoxic and exacerbates the cytotoxicity of G1 and G2. 24 hr after transfection cells were treated …
(a) Proposed model of APOL1 trafficking and cytotoxicity. All variants of APOL1 will traffic to the PM, en route they will encounter acidification and neutralization along the secretory pathway, …
FT293 cells were transfected with GCaMP6f 24 hr before imaging. Cells were then incubated with 3 µM DRAQ7 and with or without 50 ng/mL doxycycline to induce APOL1 expression. Cells were imaged via …
HEK293 cells were co-transfected with RUSH-APOL1 and GCaMP6f for 24 hr. Prior to imaging, 3 µM DRAQ7 was added and cells were treated with or without 80 µM biotin to release APOL1 from the ER. Cells …
CHO cells were co-transfected with RUSH-APOL1 and GCaMP6f for 24 hr. Prior to imaging, cells were treated with or without 80 µM biotin to release APOL1 from the ER. Cells were imaged via widefield …
CHO cells were co-transfected with RUSH-APOL1, GCaMP6f, and ER-LAR-GECO for 24 hr prior to imaging. On the day of the experiment cells were treated with 80 µM biotin and imaged for 0.5–12 hr post …
CHO cells were co-transfected with RUSH-G2 and GCaMP6f for 24 hr prior to imaging. On the day of the experiment cells were treated with 80 µM biotin and incubated in media containing 150 mM Na+ (130 …
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Recombinant DNA reagent (Homo sapiens) | APOL1-G0 | NCBI | BC143038.1 | cDNA |
Recombinant DNA reagent (Homo sapiens) | APOL1-G1 | NCBI | AF305428.1 | cDNA |
Recombinant DNA reagent (Homo sapiens) | APOL1-G2 | 1000 genomes project, this paper | cDNA *Constructed from mutagenesis from APOL1-G0. Protein coding sequence based off of 1000 genomes data | |
Recombinant DNA reagent PRG977 | PRG977 | Regeneron | ||
Recombinant DNA reagent and transfected construct pcDNA5/FRT/TO | pcDNA5 | Thermo Fisher | V652020 | APOL1 variants cloned into this plasmid to generate stable cell line (FT293-APOL1_ |
Recombinant DNA reagent and transfected construct pOG44 | p0G44 | Thermo Fisher | V600520 | |
Recombinant DNA reagent and transfected pcDNA6/Tet-repressor | pcDNA6/Tet-repressor | Thermo Fisher | R25001 | |
Recombinant DNA reagent and transfected Str-KDEL-SBP-EGFP-GPI | RUSH | Addgene | 65293 | Gift from Franck Perez. APOL1 variants cloned into this plasmid for transfection into cells (RUSH-APOL1). GFP and GPI anchor removed |
Recombinant DNA reagent and transfected pGP-CMVB-GCaMP6f | GCaMP6f | Addgene | 40755 | A gift from Douglas Kim and the GENIE project |
Recombinant DNA reagent and transfected CMV-ER-LAR-GECO1 | ER-LAR-GECO | Addgene | 61244 | A gift from Robert Campbell |
Recombinant DNA reagent and transfected CMV-FliCR | FliCR | Addgene | 74142 | A gift from Robert Campbell |
Sequence based reagent | APOL1_G0 K150E mutagenesis primers | This paper | PCR primer pair | F:5'TGAAAGAGTTTCCTCGGTTGAAAAGTGAGCTTGAGGATAAC R:5'GTTATCCTCAAGCTCACTTTTCAACCGAGGAAACTCTTTCA |
Sequence based reagent | APOL1-G0 E150 Conversion to G1 mutagenesis Round 1 (S243G) | This paper | PCR primer pair | F:5'CGGATGTGGCCCCTGTAGGCTTCTTTCTTGTG R:5'CACAAGAAAGAAGCCTACAGGGGCCACATCCG |
Sequence based reagent | APOL1-G0 E150 Conversion to G1 mutagenesis Round 2 (I384M) (Round 1 as template) | This paper | PCR primer pair | F:5'GGAGCTGGAGGAGAAGCTAAACATGCTCAACAATAATTATAAGA R:5'TCTTATAATTATTGTTGAGCATGTTTAGCTTCTCCTCCAGCTCC |
Sequence based reagent | APOL1-G0 E150 Conversion to G12 mutagenesis | This paper | PCR primer pair | F: 5'AGCTAAACATTCTCAACAATAAGATTCTGCAGGCGGAC R: 5'GTCCGCCTGCAGAATCTTATTGTTGAGAATGTTTAGCT |
Sequence based reagent | Insertion of APOL1 cDNA into pcDNA 5 vector | This paper | PCR primer pair | F: 5'ATGATATCGCCACCATGGAGGGAGCTG R: 5'ATCTCGAGTCATCACAGTTCTTGGTCCGCCTG |
Sequence based reagent | Insertion of APOL1 cDNA into RUSH vector | This paper | PCR primer pair | F: 5'ATGCCCTGCAGGAGAGGAAGCTGGAGCGAGG R: 5'ATGCTCTAGACTATCACAGTTCTTGGTCCGCC |
Cell line (Homo sapiens) | HEK293 | ATCC | CRL-1573 | |
Cell line (Homo sapiens) | FlpIn HEK 293 | Thermo Fisher | Gift from Dr. Christian Brix Folsted Andersen. Converted into FlpIn TREX293 | |
Cell line (Homo sapiens) | Conditionally Immortalized Human podocytes | Saleem et al., 2002 | Gift from Dr. Moin Saleem and Dr. Jeffrey Kopp | |
Cell line (Cricetulus griseus) | CHO | ATCC | CCL-61 | |
Antibody | Mouse anti-APOL1 | Proteintech | 66124–1-Ig | WB 1:2000 IF 1:800 |
Antibody | Rabbit anti-APOL1 | Proteintech | 11486–2-AP | WB 1:5000 |
Antibody | Rabbit anti-GAPDH | Proteintech | 10494–1-AP | WB 1:5000 |
Antibody | Rabbit anti-Calnexin | Stressgen | SPA-860 | IF 1:200 |
Antibody | Goat anti-mouse 680RD | LICOR | 92568070 | WB 1:10,000 |
Antibody | Donkey anti-rabbit 800CW | LICOR | 925–32213 | WB 1:10,000 |
Antibody | anti-rabbit Alexa 488 plus | Thermo Fisher | A32731 | IF 1:1500 |
Antibody | anti-mouse Alexa 647 | Thermo Fisher | A21236 | IF 1:1000 |
Chemical compound, drug | HCS Nuclear Mask | Thermo Fisher | H10325 | IF 1:400 |
Chemical compound, drug | DRAQ7 | Abcam | ab109202 | Live cell microscopy 3 µM |
Chemical compound, drug | Thapsigargin | Thermo Fisher | T7458 | |
Chemical compound, drug | Interferon gamma | R and D Systems | 285IF100 | |
Chemical compound, drug | Lactate dehydrogenase assay | Promega | G1781 | Cytotox 96 Non-Radioactive Cytotoxicity Assay |
Commercial assay kit | MultiTox-Fluor Multiplex Cytotoxicity Assay | Promega | G9201 | |
Commercial assay kit | Quik Change II Mutagenesis Kit | Agilent | 200523 | |
Software | TrackMate | Tinevez et al., 2017 | ||
Software | Prism | GraphPad | ||
Software | R-multicomp package | Hothorn et al., 2008 |